Susan Hutchinson

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Machine Learning

Squamous Cell Carcinoma

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Sait Ashina, E Jolanda Muenzel, Robert A Nicholson, Anthony J Zagar, Dawn C Buse, Michael L Reed, Robert E Shapiro, Susan Hutchinson, Eric M Pearlman, Richard B Lipton
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) study. Headache 64 (8) (2024)
Sait Ashina, E Jolanda Muenzel, Robert A Nicholson, Anthony J Zagar, Dawn C Buse, Michael L Reed, Robert E Shapiro, Susan Hutchinson, Eric M Pearlman, Richard B Lipton
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) study. Headache 64 (8) (2024)
Sait Ashina, E Jolanda Muenzel, Robert A Nicholson, Anthony J Zagar, Dawn C Buse, Michael L Reed, Robert E Shapiro, Susan Hutchinson, Eric M Pearlman, Richard B Lipton
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) study. Headache (2024)
Messoud Ashina, Stewart J Tepper, Uwe Reuter, Andrew M Blumenfeld, Susan Hutchinson, Jing Xia, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M Trugman
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial. Headache 63 (1) (2023)
Messoud Ashina, Stewart J Tepper, Uwe Reuter, Andrew M Blumenfeld, Susan Hutchinson, Jing Xia, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M Trugman
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial. Headache (2023)
Messoud Ashina, Stewart J Tepper, Uwe Reuter, Andrew M Blumenfeld, Susan Hutchinson, Jing Xia, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M Trugman
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial. Headache 63 (1) (2023)
Messoud Ashina, Stewart J Tepper, Uwe Reuter, Andrew M Blumenfeld, Susan Hutchinson, Jing Xia, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M Trugman
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial. Headache 63 (1) (2023)
E Anne MacGregor, Susan Hutchinson, Hongxin Lai, Brett Dabruzzo, Sung Yun Yu, Joel M Trugman, Jessica Ailani
Safety and efficacy of ubrogepant for the acute treatment of perimenstrual migraine attacks: A post hoc analysis. Headache (2023)
Andrew M Blumenfeld, Peter J Goadsby, David W Dodick, Susan Hutchinson, Chengcheng Liu, Michelle Finnegan, Joel M Trugman, Armin Szegedi
Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis. Headache 61 (3) (2021)